Pathology and pathogenesis of hepatocellular carcinoma

Digestive Diseases

Volumn 19, Issue 4, 2001, Pages 269-278

  Röcken, Christoph ^a   Carl McGrath, Stacy ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Hepatocellular carcinoma; Liver

Indexed keywords

AFLATOXIN B1; TUMOR MARKER;

ALCOHOL CONSUMPTION; APOPTOSIS; CANCER GENETICS; CANCER RISK; CELL CYCLE; CELL GROWTH; CELL INTERACTION; CHRONIC HEPATITIS; DISEASE ASSOCIATION; DNA DAMAGE; DNA METHYLATION; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; GENE CONTROL; GENE INACTIVATION; GEOGRAPHIC PATHOLOGY; GROWTH INHIBITION; HEPATITIS B; HEPATITIS C; HETEROZYGOSITY LOSS; HUMAN; IRON OVERLOAD; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC DISORDER; NONHUMAN; NUTRITIONAL STATUS; PATHOGENESIS; PRECANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR DIFFERENTIATION;

APOPTOSIS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA DAMAGE; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 0035729840     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050693     Document Type: Review

References (44)

1. Hepatocellular carcinoma: An overview
2. Multicentric or metastatic origin of hepatocellular carcinoma
3. Characteristics of multicentric hepatocellular carcinomas: Comparison with intrahepatic metastasis
4. Multicentric hepatocellular carcinomas tend to grow in more damaged segments of the liver
5. Pathology of hepatocellular carcinoma
6. Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection
7. Immunohistochemistry in the differential diagnosis of liver carcinomas
8. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver
9. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors
10. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA
11. Canalicular immunostaining of Neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas
12. Terminology of nodular hepatocellular lesions
13. Differential diagnosis of hepatocellular nodular lesions
14. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: Matched case-control study, pathological analysis, and pathogenetic hypothesis
15. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study
16. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
17. Pathology of early hepatocellular carcinoma and preneoplastic lesions in the liver
18. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants
19. Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease
20. Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases
21. Hepatocellular carcinoma without cirrhosis in the West: Epidemiological factors and histopathology of the non-tumorous liver
22. Hepatitis C virus and hepatocellular carcinoma
23. Hepatitis C virus core protein: Intriguing properties and functional relevance
24. Hepatitis C virus and its pathogenesis
25. Experimental chemical hepatocarcinogenesis
26. Impacts of chemicals on liver cancer risk
27. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?
28. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease
29. Iron and hepatocellular carcinoma
30. Genetic aspects of hepatocellular carcinogenesis
31. Absence of p51 mutation in human hepatocellular carcinoma
32. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
33. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma
34. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma
35. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
36. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepa-tocellular carcinomas
37. Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients
38. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: Report of 46 cases
39. PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas
40. PTEN/MMAC1 mutations in hepatocellular carcinomas
41. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells